Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. Lax-A-Day: new PEG oral laxativePendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. Clinical in Brief: Incidental findings common in cervical spine CTs Quebec MDs score win with skier helmet law Don't let terminal diagnosis end patient communicaiton ORTHOPEDICS: Stop-smoking program cuts complications after fracture surgery ORTHOPEDICS: Canadians debunk hip resurfacing hype Meeting also highlights growing concern over adverse reactions to metal-on-metal implants Medicine's power to transform BAD ADVICE: Sudoku and real doctors First Previous 2238 2239 2240 2241 2242 Next Last
